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IgLON proteins are GPI anchored adhesion molecules that control neurite outgrowth.
In particular, Negr1 down-regulation negatively influences neuronal arborization in vitro
and in vivo. In the present study, we found that the metalloprotease ADAM10 releases
Negr1 from neuronal membrane. Ectodomain shedding influences several neuronal
mechanisms, including survival, synaptogenesis, and the formation of neurite trees.
By combining morphological analysis and virus-mediated selective protein silencing in
primary murine cortical neurons, we found that pharmacologically inhibition of ADAM10
results in an impairment of neurite tree maturation that can be rescued upon treatment
with soluble Negr1. Furthermore, we report that released Negr1 influences neurite
outgrowth in a P-ERK1/2 and FGFR2 dependent manner. Together our findings suggest a
role for Negr1 in regulating neurite outgrowth through the modulation of FGFR2 signaling
pathway. Given the physiological and pathological role of ADAM10, Negr1, and FGFR2,
the regulation of Negr1 shedding may play a crucial role in sustaining brain function and
development.
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INTRODUCTION
Neurite outgrowth is a fundamental process that allows the establishment of functional wiring
in the developing brain. This process can be summarized as a mechanism where extracellular
cues bind to transmembrane receptors and trigger signaling cascades which eventually reorganize
neuronal structure (Raper and Mason, 2010). Therefore, understanding how neuronal projections
calibrate their responses to developmental cues might provide critical information about how the
brain builds functional connectivity. Several families of transmembrane or membrane proteins,
such as semaphorin, neuroligin, neurexin, and immuno-globulin super families, have been
implicated in the regulation of neurite formation (Maness and Schachner, 2007). IgLONs are
adhesion protein belonging to the immunoglobulin superfamily. IgLON members are highly
glycosylated proteins, possess three C2-type Ig-like domains and bind to the lipid membrane
by a GPI-anchor (Miyata et al., 2003). Accumulating evidence indicates that IgLON are
tightly implicated in neuronal functions such as synaptic formation, plasticity, and neurite tree
development (Gil et al., 1998; Schäfer et al., 2005; Hashimoto et al., 2008, 2009; Pischedda et al.,
2014; Sanz et al., 2015). In particular, it has been suggested that each IgLON protein can promote
or inhibit neuronal maturation depending on the particular complement of IgLON expressed
at the surface (Hashimoto et al., 2009). IgLON proteins may form homophilic and heterophilic
complexes at the cell surface or with juxtaposed cells to modulate adhesion and neurite outgrowth.
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For example LSAMP facilitates the extension of neurites
from neurons expressing LSAMP while it inhibits branch
formation in neurons that do not express LSAMP (Mann
et al., 1998). Furthermore, it has been demonstrated that two
IgLON members, neurotrimin (Gil et al., 1998), and LSAMP
(Zhukareva et al., 1997) can be released and act to regulate
neurite outgrowth. We have previously described the role of the
IgLON family member Negr1 in regulating neurite arborization
(Pischedda et al., 2014). In this previous study, we observed that
neurons lacking endogenous Negr1 display a clear morphological
phenotype -with a reduction of dendrite length and number
compared to wild type cells- suggesting that Negr1 positively
modulates neuronal tree growth. The mechanism underlying
Negr1 impact on neuronmorphology, however, remains obscure.
Strikingly, it has been recently demonstrated that IgLONs
family members, including Negr1 can be shed from the
surface of cortical neurons through a metalloprotease dependent
proteolytic pathway (Sanz et al., 2015). In the study reported here,
we found that the metalloprotease ADAM10 cleaves Negr1 from
neuronal membrane and characterized the impact of ADAM10-
Negr1 on neuronal structural development. In particular, we
found that released Negr1 influences neuronal morphology by
activating a pathway that requires FGFR2 receptor and ERK1/2
phosphorylation.
MATERIALS AND METHODS
Lentiviral Vector Constructs, Virus
Production, and Plasmids
Negr1 and FGFR2 target sequences were identified, synthesized,
and cloned into GFP-expressing pLVTH, as previously described
(Zhou et al., 2006; Bauer et al., 2009; Pischedda et al., 2014). In
brief, oligonucleotides (oligo-nt) coding for a 5′-pseudoBglII-
site, a sense-oligo-nt-loop-antisense-oligo-nt, transcription
termination site, and a 3′pseudo-XbaI-restriction-site were
purchased from Metabion. Sense and antisense oligos were
annealed and subsequently phosphorylated. The fragments were
cloned 3′ to the H1-promoter of pBC KS+(ClaI)-H1, resulting
in pBC KS+(ClaI)-sh. The H1sh cassettes were isolated with
ClaI, blunted, and cloned into the blunted ClaI/BamH1 site
of pLV transfer-vector. pLV is a modified plasmid transfer
vector derived from original pLVTH (Wiznerowicz and
Trono, 2003), in which the BamH1-tetO-H1-ClaI fragment
was excised. All recombinant lentiviruses were produced by
transient transfection of HEK293T cells according to standard
protocols (Wiznerowicz and Trono, 2003). Primary neuronal
cultures were transduced with viruses at multiplicity of infection
(MOI) 3 if not otherwise specified. mNegr1 cDNA (Addgene
clone C3342IRCKp5014P057-rzpdm13–21) was cloned into
strep-FLAG pcDNA3.1 vector (Gloeckner et al., 2009).
Negr1 Purification and Deglycosylation
For protein purification, HEK293 cells transfected with strep-
FLAG Negr1 were lysed in RIPA buffer (150mM NaCl, 50mM
HEPES, 0.5%NP40, 1% Sodium-deoxycholate) for 1 h at 4◦C and
then processed for streptavidin immunoprecipitation. Protein
were eluted from STREP resin in elution buffer (2.5mM
Desthiobiotin, 100mM Tris-HCL, 150mM NaCl, 1mM EDTA)
in mild agitation for 1 h at 4◦C. The protein concentration was
measured via standard Bradford assay (Bio-Rad) and protein
purity was assessed by SDS-PAGE followed by silver staining.
Where indicated, after purification strep-FLAG Negr1 was
treated with PNGase F (5 units, 20min, 37◦C; Sigma-Aldrich,
Germany) and then analyzed by western blotting.
Neuronal Cultures and Drugs
Cortical neuron cultures were prepared from mouse embryos
(E17.5–18.5; strain C57BL/6). High-density (750–1000
cells/mm2) and medium-density (150–200 cells/mm2) neuronal
cultures were plated and grown on 6-well plastic tissue culture
plates (Iwaki; Bibby Sterilin Staffordshire, UK) or on 12mm
diameter coverslips put into 24-well plastic tissue culture plates
as previously described (Iwaki; Bibby Sterilin; Piccoli et al., 2007).
In these cultures glial growth is reduced to less than 0.5% of the
nearly pure neuronal population (Brewer et al., 1993). Neurons
were treated daily with FGFb 20 ng/ml, FGF7/KGF 20 ng/ml, IGF
5 ng/ml (all from Peprotech, NJ USA) or every second day with
GI 254023X 20µM (TOCRIS Bioscience, UK) or MEK inhibitor
U0126 100 nM (Sigma-Aldrich). Strep-FLAG-Negr1, 40 ng/ml,
was performed at DIV10. The National and Institutional Animal
committees have approved all the procedures involving animal
present in this work (IACUC 625).
Biochemistry and Antibody
Neurons were washed in PBS and lysed in RIPA buffer
(150mM NaCl, 50mM HEPES, 0.5% NP40, 1% Sodium-
deoxycholate). After 1 h under mild agitation, lysate was clarified
by centrifugation for 20min at 16,000g. All procedures were
performed at 4◦C. Protein sample were measured via standard
Bradford assay (Bio-Rad. USA). For protein identification and
relative quantification via Western blotting, a proper volume
of sample containing an equal amount of proteins was diluted
with 0.25% 5X Laemmli buffer and loaded onto 10% SDS-PAGE
gels; the proteins were transferred onto nitrocellulose membrane
(Sigma-Aldrich) at 80V for 120min at 4◦C.
The primary antibodies were applied overnight in a blocking
buffer (20mM Tris, pH 7.4, 150mM NaCl, 0.1% Tween 20, and
5% nonfat dry milk); primary antibodies (source in parentheses)
included rabbit anti- FGFR2 1:200 (Santa Cruz Biotechnology,
USA), goat anti-Negr1 1:1000 (R&D, USA), mouse anti-NCAM
1:1000 (BD Biosciences, USA), rabbit anti-GFP 1:5000 (Life
Technology, USA), mouse anti-Actin 1:2000 (Sigma-Aldrich),
rabbit anti RpS6 1:2000, rabbit anti-p42/44(pERK), and rabbit
anti-42/44 (ERK; Cell Signaling, USA). The secondary antibodies
(HRP-conjugated anti-mouse, anti-rabbit, or anti-rat; Jackson
ImmunoResearch, UK) were used in a ratio of 1:8000. The signal
was detected using an ECL detection system (GE Healthcare).
Films were acquired on a GS-800 densitometer (BioRad)
calibrated following the manufacturers’ instructions, and protein
abundance was estimated as a function of the optical density
of a specific band quantified by ImageJ software (NIH). Unless
otherwise stated, all the other chemicals were purchased from
Applichem, Germany.
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Immunofluorescence and Quantification
Neuronal cultures were infected with viruses at days in vitro
(DIV) 1–2 or transfected at DIV4 with Lipofectamine 2000
following manifacture’s protocol (Life Technology). For the
immunostaining experiments, neurons were fixed at DIV 18
in 4% paraformaldehyde and 4% sucrose at room temperature.
GFP positive neurons were randomly chosen for quantification.
The fluorescence images were acquired in blind using a LSM
Zeiss 510 confocal microscope with Zeiss 63X objective (Karl
Zeiss, Jena, Germany) at a resolution of 2048 × 2048 pixels,
pixel size = 0.098mm. All the measurements were performed
in blind using NeuronStudio (available at http://research.mssm.
edu/cnic/tools.html). Neurites were automatically traced and
quantified by the software in terms of length, number and
morphology (Wearne et al., 2005; Rodriguez et al., 2008). In
our analysis neurite number represents the total number of
segments. Data were then logged and analyzed in Microsoft
Excel.
Statistical Analysis
All data are expressed as mean ± SEM. Data were analyzed with
an unpaired Student’s t-test (two classes) or ANOVA followed by
Tuckey’s post hoc-test (more than two classes). The indication
level of significance (p) is indicated for specific experiments
throughout the text and in Supplementary Table 1. For the
analysis of neurons morphology in the different experimental
condition we considered at least 12 cells randomly chosen in at
least four experiments.
RESULTS
Negr1 Modulates Neurite Tree
Recent evidence suggested that IgLONs members, including
Negr1, are released into the extracellular space via
metalloproteinase and that metalloproteinase activity on
IgLONs has an impact on neuronal maturation (Sanz et al.,
FIGURE 1 | Negr1 influences neuritic tree formation. Cortical neurons were infected at DIV4 with low (MOI = 0.3) or high (MOI = 3) titer of viruses expressing
GFP and scramble siRNA (siControl) or siRNA against Negr1 (siNegr1). Infection with low or high viral titer resulted in different infection efficiency, evaluated as fraction
of GFP positive cells within the entire population, stained with DAPI. Data are expressed as mean ± SEM, n = 4. *p < 0.05 vs. not infected (n.i.), #p < 0.05 vs. low
infection (A). Cells were solubilized and then assassed by immuno-blotting at DIV18 (B). The graph reports the optical density of the band relative to Negr1 protein,
normalized vs. S6 ribosomial protein (S6 rib) value. Data are expressed as mean ± SEM, n = 4. *p < 0.05 vs. not infected (n.i.), #p < 0.05 vs. low infection (C).
Neurons were infected at DIV4 and processed for immunofluorescence at DIV18. Panels show camera lucida tracing (D). Graphs show neurite total length and
number (E). Data are reported as mean ± SEM; *p < 0.01 vs. siControl (CTRL), #p < 0.05 vs. low infection. Scale bar = 50µm.
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2015). We have previously showed that Negr1 influences
neuritic tree development (Pischedda et al., 2014). In the light
of these findings, Negr1 may influence neuronal morphology
acting in cis as a membrane bound protein and/or in trans as a
soluble protein. To investigate these two scenarios, we infected
cortical neurons at DIV4 with viruses expressing GFP marker
together with either Negr1 specific siRNA (siNegr1) or scramble
control (siControl) following two experimental paradigms:
(1) cultures infected with a high viral titer (MOI = 3); (2)
cultures infected with a low viral titer (MOI = 0.3). In both
cases, cultures were processed for subsequent investigation at
DIV18. Biochemical and imaging analysis showed that the titer
of infection influenced the extent of both infection efficiency
and Negr1 protein reduction (Figures 1A–C). Next we studied
the morphology of GFP positive neurons in the two different
conditions. Interestingly we reported that cultures exposed to
high viral titer show a more pronounced reduction in terms of
neurite number and length than cultures exposed to low viral
titer (Figures 1D–E, Supplementary Figure 3A, and Table 1).
These data suggest that the overall amount of Negr1 expressed
by cells influences neuronal morphology.
Negr1 Shedding by ADAM10 Modulates
Neurite Tree Formation
To confirm the biological relevance of Negr1 as soluble factor,
we investigated in detail the presence of Negr1, NCAM, and
S6 ribosomial protein, a well-established cytoplasmic marker, in
samples prepared from neuronal culture at DIV18 or from the
relative conditioned media. As expected, we detected all three
proteins in the cellular lysate, but only Negr1 and NCAM in
the media. It is well established that NCAM can be released by
shedding via ADAM10 (Brennaman et al., 2014). Interestingly,
when we treated neurons from DIV10 to DIV18 with the well
characterized ADAM10 inhibitor, GI 254023X (20µM, every
second day), we noticed a robust reduction of the fraction of
NCAM and Negr1 protein released in the media (Figures 2A–C).
These experiments suggest that Negr1 can be shed from neuronal
membrane by ADAM10. Sanz and colleagues previously
demonstrated that metalloproteinase inhibitors severely impair
neuronal morphological development in an IgLON dependent
manner (Sanz et al., 2015). Consequently, we studied the
morphological phenotype in cortical cultures treated with DMSO
or with the ADAM inhibitor GI 254023X (20µM, every
second day) from DIV10 to 18. Analysing the incidence of
pyknotic nuclei suggested that GI 254023X did not induce overt
toxicity (Supplementary Figures 2A,B). Notably, we observed
that chronic inhibition of ADAM reduced the total number of
neurite as well as the number of first and second order neurite
(Figures 2D–E, Supplementary Figures 1, 3B and Table 1).
ADAM10 is involved in processing (and shedding) several
membrane proteins implicated in neurite outgrowth, including
NCAM, N-Cadherin, and L1-NCAM (Mechtersheimer et al.,
2001; Jorissen et al., 2010; Paudel et al., 2013; Brennaman et al.,
2014). We therefore sought to assess the direct contribution
of soluble Negr1 to the regulation of neuron morphology
via ADAM10. To achieve this, we purified 2XStrep-FLAG
epitope tagged Negr1 (rNegr1) from transfected HEK293 cell
TABLE 1 | The table reports neurite total length and number for each
experimental condition investigated.
Infection Treatment Total length ± S.E. Number ± S.E.
siControl Not treated 1587.15± 58.67 23.47± 1.04
siNegr1 Low MOI 1347± 57.3 16.06± 0.93
siNegr1 High MOI 1084.82± 41.54 14± 0.66
siControl rNegr1 2043.5± 76.98 30.42± 1.26
siControl GI 254023X 590.2± 42.72 10.1± 0.55
siControl GI 254023X + rNegr1 1169.7± 90.17 19.5± 1.96
siNegr1 rNegr1 1673.64± 71.23 25.61± 1.09
siControl U0126 787.05± 58.94 12.95± 0.8
siControl U0126 + rNegr1 742.7± 43.63 11± 0.62
siControl FGFb 1654.43± 57.1 25.43± 1.06
siControl FGF7 2105± 84.93 31.5± 1.18
siControl IGF 1612.18± 87.14 26.06± 1.19
siNegr1 FGFb 1505.88± 64.04 22.54± 1.03
siNegr1 FGF7 1686.14± 62.18 26.86± 0.9
siNegr1 IGF 1398.91± 62.28 19.23± 0.98
siFGFR2 Not treated 1032.15± 121.67 16.35± 1.66
siFGFR2 rNegr1 945.82± 117.68 16.68± 1.81
Data are shown as mean ± SEM.
using streptavidin resin. Protein purity was monitored by
silver-staining (Supplementary Figure 2C). Negr1 is highly and
specifically glycosylated in vivo (Miyata et al., 2003). Upon
immuno-blot analysis, we detected rNegr1 as a band with an
apparent molecular weight (MW) of 50 KDa, corresponding
to the glycosylated form of Negr1. Upon incubation with the
N-linked deglycosilase PNGase, we detected a protein band
with an apparent MW of 38 KDa, corresponding to the MW
predicted for unmodifed Negr1 (Expasy database, entry: Q80Z24;
Supplementary Figure 2D). Thus, exogenous expression of
rNegr1 resulted in a protein that possesses some of the molecular
features of endogenous Negr1. Purified rNegr1 was administered
to either DMSO or ADAM10 inhibitor treated cortical neuron
at DIV10 at concentration of 40 ng/ml. Cells were fixed at
DIV18 and processed for immunofluorescence. We observed
that rNegr1 treatment influenced positively the morphology of
ADAM10 inhibited neurons. Furthermore, rNegr1 treatment was
associated to an increase of neurite number and length in DMSO
treated neurons (Figures 2D,E, Supplementary Figures 1, 3B
and Table 1). Taken together, these data support a role for soluble
Negr1 released by ADAM10 in the modulation of neuronal
morphology.
Soluble Negr1 Influences Neuron
Morphology Acting via FGFR2
Biochemical studies suggest that IgLON proteins can form
stable homodimers (Miyata et al., 2003). We therefore set
out to test whether soluble rNegr1 executes its function via
binding endogenous Negr1 expressed on neuronal membrane.
To address this, we investigated the impact of soluble rNegr1 on
cortical neuronal cultures where endogenous Negr1 expression
had been down-regulated. Cortical neurons were infected at
DIV4 with viruses expressing GFP together with Negr1 specific
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FIGURE 2 | ADAM10 activity modulates neuritic tree development. Cortical neurons were infected at DIV4 with siControl and then treated every second day
with DMSO (20µM, not treated) or with ADAM10 inhibitor GI 254023X (20µM) from DIV10 to DIV18. Cells and relative conditioned media were assayed for
western-blotting to measure NCAM, Negr1, and S6 ribosomial protein level (A). Graphs show NCAM, Negr1 level in the cellular lysate expressed as optical density,
normalized vs. and S6 ribosomial protein (S6 rib) value (B) and the extent of Negr1 and NCAM release in media expressed as percentage of the relative amount
measured in cellular lysate (C). Data are reported as mean ± SEM; n = 6, *p < 0.05 vs. not treated. Cortical neurons were infected with siControl virus at DIV4 and
treated every second day from DIV10 to DIV18 with DMSO (not treated, NT) or with ADAM10 inhibitor GI 254023X (20µM, GI) and/or recombinant Negr1 (40 ng/ml,
single administration at DIV 10, rNegr1). Neurons were processed for immunofluorescence at DIV18 and GFP positive neurons imaged via confocal microscopy.
Panels show camera lucida tracing (D). Graphs show neurite total length and number (E). Data are reported as mean ± SEM; *p < 0.001 vs. not treated (NT);
◦p 0.001 vs. GI 254023X (GI). Scale bar = 50µm.
siRNA (siNegr1) or scramble siRNA (siControl) and treated
at DIV10 with soluble rNegr1. As already observed, the
abolishment of endogenous Negr1 expression correlated with a
reduction of neuritic tree complexity (Pischedda et al., 2014).
Intriguingly, the morphological effect of rNegr1 was evident also
in Negr1 silenced neurons. In fact, rNegr1 treatment was able
to rescue the morphological phenotype resulting from Negr1
silencing (Figure 3, Supplementary Figure 4A, and Table 1).
This evidence suggests that the formation of a Negr1 homodimer
is not strictly required for the morphological effect associated
with the exposure to soluble Negr1. Instead, soluble Negr1 may
associate with other proteins to influence neurite outgrowth. The
ERK1/2 pathway had been recognized as a key player in neurite
outgrowth (Maness and Schachner, 2007). We therefore sought
to test if soluble Negr1 could influence neuronal morphology
via the ERK1/2 signaling pathway. To this aim, we administered
MEK inhibitor U0126 from DIV10 to DIV18 (100 nM, daily)
to rNegr1 or control treated neurons. U0126 did not induce
overt toxicity as assessed by the incidence of pyknotic nuclei
(Supplementary Figures 2A,B). As expected, MEK inhibition
significantly impaired neuron morphology. Noteworthy, Negr1
treatment was not able to rescue the morphological changes
due to MEK inhibitor both in term of total process length or
number (Figures 4A,B, Supplementary Figure 4B, andTable 1).
Cumulatively, these data suggest that Negr1 influences neuritic
tree outgrowth activating a pathway that requires proper ERK1/2
phosphorylation. It has been demonstrated that IgLONmembers
are able to influence tyrosine kinase associate receptor (RTK;
McKie et al., 2012). Furthermore, it is well established that
RTK regulate neuronal morphology via the ERK1/2 pathway
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FIGURE 3 | Homodimerization is not essential to execute rNegr1 morphological effect. Cortical neurons were infected with siControl or siNegr1 virus at DIV4
and treated with recombinant Negr1 (40 ng/ml, single administration at DIV 10, rNegr1). Neurons were processed for immunofluorescence at DIV18 and infected GFP
positive neurons imaged via confocal microscopy. Panels show camera lucida tracing (A). Graphs show neurite total length and number (B). Data are reported as
mean ± SEM; *p < 0.001 vs. not treated, same infection, #p < 0.001 vs. siControl, same treatment. Scale bar = 50mm.
(Hausott et al., 2009). Consequently, we screened a battery
of RTK agonists for their ability to rescue the phenotype
associated to Negr1 silencing. Cortical neurons were treated
from DIV10 to 18 with IGF (5 ng/ml), FGFb (20 ng/ml), and
FGF7 (20 ng/ml). We observed that the treatment with RTK
agonists rescued the Negr1 silencing phenotype. Furthermore,
we found that FGF7, a specific FGFR2 agonist, induced a more
robust increase in neurite number in siNegr1 neurons compared
to the other RTK agonists. Similarly, when we administered
RTK agonists to control infected cells, only FGF7 treatment was
associated to a significant increase in neuritic tree complexity
(Figure 5, Supplementary Figure 5, and Table 1). However,
when we investigated ERK1/2 pathway activation in neuronal
cultures by immuno-blotting, we did not observe any significant
increase in ERK1/2 phosphorylation upon chronic treatment
with the different agonists (Supplementary Figures 2E,F). To
further assess the potential functional correlation among Negr1,
FGFR2, and neurite outgrowth, we studied neuron morphology
upon acute FGFR2 silencing. To this aim, we took advantage
of silencing construct targeting specifically FGFR2 mRNA
sequence (Zhou et al., 2006). This construct was able to
efficiently down-regulate FGFR2 expression in cortical neurons
(Supplementary Figures 2G,H). Cortical neurons were infected
at DIV4 with siFGFR2 or control virus, treated or not with
soluble rNegr1 at DIV10 and imaged at DIV18. We noticed
that FGFR2 silencing was associated with a robust reduction of
neuritic tree complexity. Furthermore, we did not observe any
increase in neurite number or total length upon rNegr1 treatment
in siFGFRF2 neurons (Figures 6A,B, Supplementary Figure 6,
and Table 1). Dendritic spines constitute the main postsynaptic
elements of excitatory synapses (Tada and Sheng, 2006). Previous
reports, including our own, indicated that Negr1 modulated
dendritic spine number (Hashimoto et al., 2009; Pischedda et al.,
2014). Thus, we imaged dendritic protrusions treated or not
with soluble rNegr1. The quantification of spine number and
morphology indicated that rNegr1 treatment correlates with an
increase in total spine number. To investigate the potential
involvement of FGFR2 on this effect, we treated or not with
rNegr1 neuronal cultures down-regulated for FGFR2 expression.
Interestingly we noticed that FGFR2 silencing did not have
an impact on spine number in control treated cultures but
abolished the positive effect reported upon Negr1 treatment
(Figures 6C,D).We then investigated whether Negr1 can activate
the FGFR2 dependent intracellular pathway. To achieve this,
siControl and siFGFR2 infected neurons were treated with
rNegr1 (40 ng/ml, 10min) and processed for immuno-blotting
to assess the activation of ERK1/2 pathway. These data indicated
that acute Negr1 treatment induces ERK1/2 phosphorylation in
siControl but not in siFGFR2 neurons (Figures 6E,F). Taken
together, these findings suggest that soluble Negr1 influences
neuron morphology in a FGFR2 dependent manner.
DISCUSSION
Our data suggest that Negr1 connects ADAM10 and FGFR2
in a pathway that regulates neurite outgrowth in a ERK1/2
dependent manner. In particular, we provided evidence that
ADAM10 shedding releases Negr1 into the extra-cellular space.
ADAM10 modulates axonal growth via the cleavage of different
membrane proteins including L1-NCAM, N-cadherin, and
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FIGURE 4 | MEK inhibition abolishes morphological effect of Negr1. Cortical neurons were infected with siControl virus at DIV4 and treated every second day
from DIV10 to DIV18 with DMSO or with MEK inhibitor U0126 (100 nM, IN) and/or recombinant Negr1 (40 ng/ml, single administration at DIV 10, rNegr1). Neurons
were processed for immunofluorescence at DIV18 and infected GFP positive neurons imaged via confocal microscopy. Panels show camera lucida tracing
(A). Graphs show neurite total length and number (B). Data are reported as mean ± SEM; *p < 0.001 vs. not treated (NT), ◦p < 0.001 vs. rNegr1. Scale bar = 50µm.
NCAM (Mechtersheimer et al., 2001; Hinkle et al., 2006; Paudel
et al., 2013). We propose that Negr1 acts as a novel ADAM10
substrate involved in neuronal morphogenesis. In a previous
study, Sanz and colleagues did not observe any difference in
term of Negr1 release upon ADAM10 acute silencing (Sanz
et al., 2015). In contrast, in our study we abolished ADAM10
activity pharmacologically via chronic treatment with specific
inhibitor. This experimental difference may account for the
opposite outcome we reported here.
We propose that soluble Negr1 positively influences neuron
maturation by stimulating an intracellular signaling cascade, i.e.,
acting in trans. Given the outcome we report upon interference
with FGFR2 pathway, we suggest that Negr1 triggers ERK1/2
phosphorylation and modulates neurite outgrowth via activation
of FGFR2. Accordingly, we describe that acute treatment with
rNegr1 triggers ERK1/2 phosphorylation via FGFR2 and that
rNegr1 does not influence the morphology of FGFR2 silenced
neurons. It is noteworthy, however, that we were unable
to detect sustained ERK1/2 phosphorylation upon chronic
exposure to rNegr1. Similarly, we did not observe an increase
in ERK1/2 phosphorylation upon chronic stimulation with
RTK agonists such as IGF, FGFb, or FGF7. The intrinsically
transient nature of ERK1/2 signaling might explain this outcome.
Alternatively, chronic Negr1 treatment may influence neuronal
maturation via a FGFR2 dependent pathway other than ERK1/2
phosphorylation (Mansukhani et al., 2005; Katoh, 2009; Stevens
et al., 2010), being in any case ERK1/2 signaling necessary to
support proper neurite outgrowth. In any case, chronic treatment
with RTK agonist positively influenced the morphology of Negr1
silenced neurons. Thus, RTK agonist and Negr1 may activate
a common pathway impinging on ERK1/2 phosphorylation.
Interestingly, it is known that FGFR2 signaling via ERK1/2
triggers the phosphorylation and activation of the transcription
factor CREB, which modulates neurite outgrowth (Maness and
Schachner, 2007). It is tempting to speculate that Negr1 activates
a similar signaling cascade. Released Negr1 may stimulate
neurite outgrowth via a mechanism similar to the one reported
for another ADAM10 substrate, NCAM (Bonfanti, 2006). In
fact released NCAM ectodomain stimulates neurite outgrowth
triggering ERK1/2 signaling via binding with β1 integrin (Diestel
et al., 2005). The data reported here together with our previous
publication (Pischedda et al., 2014), show that acute Negr1 down-
regulation severely impairs neurite outgrowth. Thus, a neurite
outgrowth promoting role for Negr1 in cis has to be taken
into account. Indeed, we also observed a clear morphological
defect upon infection with low titer of Negr1 siRNA viruses.
Under these conditions, scarce and isolated Negr1 silenced
neurons were surrounded by cells expressing and therefore
releasing Negr1. In this experimental setting we observed a clear
impairment of neuritic tree complexity upon Negr1 silencing.
The magnitude of the effect was, however, lower than that
reported upon high viral titer infection, i.e., upon massive and
general down regulation of Negr1 protein levels in the cultured
neurons. These results suggest that Negr1 influences neuronal
development acting both in cis and in trans and that the two
mechanisms contribute to determining neurite outgrowth. We
propose that Negr1 may act in trans via FGFR2; however, the
precise molecular mechanism underlying Negr1 role in cis has yet
to be determined. We propose a model where membrane bound
Negr1 forms a heterocomplex with FGFR2 and influences its
downstream signal upon agonist binding (including potentially
soluble Negr1 itself as well as FGFs) as reported for NCAM
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FIGURE 5 | FGFR2 activation ameliorates morphological effect due to Negr1 down-regulation. Cortical neurons were infected with siControl or siNegr1 virus
at DIV4 and treated daily from DIV10 to DIV18 with IGF (5 ng/ml), FGFb (20 ng/ml), and FGF7 (20 ng/ml). Neurons were processed for immunofluorescence at DIV18
and infected GFP positive neurons imaged via confocal microscopy. Panels show camera lucida tracing (A). Graphs show neurite total length and number (B). Data
are reported as mean ± SEM; *p < 0.001 vs. siControl, same treatment, ◦p < 0.001 vs. not treated, same infection (NT), #p < 0.01 vs. FGFb or IGF, same infection.
Scale bar = 50µm.
(Kiselyov et al., 2005; Francavilla et al., 2007, 2009). Indeed Negr1
may not bind directly FGFR2 or instead FGFR2-Negr1 hetero
complex is quite unstable, given that we were unable to confirm
Negr1-FGFR2 interaction by the means of classic biochemical
approaches (data not shown). Several experimental findings
connect ADAM10 and FGFR2 to the regulation of neuronal
functional and morphological maturation. Indeed, FGFRs play
essential roles in almost every step during embryonic brain
development (Goetz and Mohammadi, 2013). Axonal path-
finding in the visual system and in the peripheral nervous
system rely on guidance mechanisms involving FGFRs (Haupt
and Huber, 2008). In particular, FGFR2 signaling regulates
axon patterning modulating the expression of the repulsive
guidance cue Sema3A during innervation (Kettunen et al., 2007).
Furthermore, the deletion of FGFR2 results in decreased volume
of subcortical whitematter due to dramatically reduction number
of axonal fibers (Vaccarino et al., 2009). Finally, given that
FGFRs signaling has a prominent role in the maturation and
migration of neurons (Smith et al., 2006; Stevens et al., 2010;
Müller Smith et al., 2012), it is tempting to speculate about
a putative role for Negr1 in overall CNS development. Taken
together, our data suggest a possible functional link among
Negr1, ADAM10, and FGFR2. It is also of note that all three
of these proteins have been linked to different neurological
disorders. Independent genetic studies have linked both Negr1
and FGFR2 to autism (Pinto et al., 2010; Hussman et al., 2011;
Casey et al., 2012; Michaelson et al., 2012; Neale et al., 2012).
Although the mechanisms that lead to autism are at best poorly
understood, recent findings on neurological functioning point to
altered brain connectivity as a key feature in this disorder (Vissers
et al., 2012; Coskun et al., 2013; Schaer et al., 2013). Alteration of
Negr1 expression has been described in two other neurological
disorders characterized by marked connectivity dysfunctions,
namely dyslexia (Veerappa et al., 2013) and schizophrenia
(Holliday et al., 2009), suggesting that Negr1 plays pivotal role
in the establishment of a functional wiring. Finally, altered levels
of Negr1 have been observed in the CSF of psychiatric patients,
raising the possibility that soluble Negr1 may be pathologically
relevant (Maccarrone et al., 2013). Finally, ADAM10 has been
implicated in the pathogenesis of Alzheimer’s disease (AD):
ADAM10 possesses alpha-secretase activity, involved in the
alternate amyloid precursor protein processing pathway to the
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FIGURE 6 | Negr1 modulates neuron morphology via FGFR2. Cortical neurons were infected at DIV4 with virus expressing siControl or siRNA against FGFR2
(siFGR2) and treated at DIV10 with recombinant Negr1 (40 ng/ml, rNegr1). Neurons were processed for immunofluorescence at DIV18 and infected GFP positive
neurons imaged via confocal microscopy. Panels show camera lucida tracing (A). Graphs show neurite total length and number (B). Data are reported as mean ±
SEM; *p < 0.001 vs. not treated, same infection, #p < 0.01 vs. siControl, same treatment. Scale bar = 50µm. Dendritic spines were recognized as mushroom like
protrusions decorating the neurites (C). Spine density was calculated as protrusion number along 10µm of neuritic length. Data are reported as mean ± SEM;
*p < 0.001 vs. not treated, same infection, #p < 0.01 vs. siControl, same treatment. Scale bar = 10µm (D). Cortical neurons were infected with virus expressing
siControl or siRNA against FGFR2 (siFGR2) and treated with recombinant Negr1 (40 ng/ml, rNegr1 10min). Neurons were processed for western-blotting to
investigate ERK1/2 phosphorylation (E). The graph reports p-ERK1/2 level normalized vs. total ERK1/2 amount (F). Data are expressed as mean ± SEM n = 5.
**p < 0.01 vs. not treated, same infection; #p < 0.01 vs. siControl, same treatment.
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beta-secretase pathway that produces amyloid beta (Lammich
et al., 1999). Two rare ADAM10 variants, Q170H, and R181G,
have been correlated with AD and result in defective alpha-
secretase activity (Kim et al., 2009; Suh et al., 2013). It would
be interesting to study whether Q170H and R181G mutations
impair also Negr1 shedding and eventually evaluate the potential
role of soluble Negr1 in such models. In conclusion, our data
show that Negr1 has the ability to influence neuronal signaling
during neuronal network formation acting both as a membrane
bound protein as well as a soluble factor. Given its possible
implication with several neurological disorders, clarifying the
function of Negr1 and the underlying biological pathways linked
to neuronal function may provide a potential target for future
therapeutic intervention.
AUTHOR CONTRIBUTIONS
FP performed and designed experiments; GP designed
experiments and wrote the paper.
ACKNOWLEDGMENTS
GP is grateful to the Michael J. Fox Foundation, to the
Fondazione Telethon (grant GGP12237), to Regione Lombardia
(Projects MbMM-Convenzione No. 18099/RCC) and to
Fondazione Grigioni per il morbo di Parkinson. We thank
Dr. Patrick Lewis, University of Reading, for his careful and
critical reading of our manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnmol.
2015.00089
Supplementary Figure 1 | Cortical neurons were infected with siControl
virus at DIV4 and treated every second day from DIV10 to DIV18 with
DMSO (not treated, NT) or with ADAM10 inhibitor GI 254023X (20 µM)
and/or recombinant Negr1 (40 ng/ml, single administration at DIV 10,
rNegr1). Neurons were processed for immunofluorescence at DIV18 and GFP
positive neurons imaged via confocal microscopy. Graph shows the number of
neurite belonging to 1st, 2nd, 3rd, and 4th order. Data are reported as mean ±
SEM; ∗p < 0.01 vs. not treated, ◦p 0.001 vs. GI 254023X.
Supplementary Figure 2 | Cortical neurons were treated daily from DIV10
to DIV18 every second day with GI 254023X (GI, 20 µM) or MEK inhibitor
U0126 (U0126, 100nM). At DIV18 cells were processed for imaging and stained
with DAPI to detect nuclei. The presence of pyknotic/condensed nuclei (indicated
with an arrow) reveals cell toxicity. Scale bar = 50µm (A). The graph reports the
percentage of pyknotic nuclei. Data are expressed as mean ± SEM (B).
Recombinant Negr1 (rNegr1) was purified on streptavidin resin from transfected
HEK293 cells. Protein purity was assessed by SDS-PAGE followed by silver
staining. (C, left). The plot indicates optical density measured along the gel lane,
expressed in arbitrary unit (C, right). rNegr1 was treated or not with PNGase (5
units, 20min, 37◦C) and then analyzed by western blotting. Fully glycosylated
rNegr1 runs at the apparent molecular weight of 50 kDa (D). Cortical neurons
were treated daily from DIV10 to DIV18 with IGF (5 ng/ml), FGFb (20 ng/ml), and
FGF7 (20 ng/ml) or with rNegr1 (40 ng/ml, single administration at DIV10). At
DIV18 cells were processed for western-blotting analysis. We did not observe a
clear induction of ERK1/2 phosphorylation upon treatment with the different
molecules (E). The graph reports p-ERK1/2 level normalized vs. total ERK1/2
amount. Data are expressed as mean ± SEM N = 5 (F). Cortical neurons were
infected at DIV4 with virus expressing siControl or siRNA against FGFR2 (siFGR2)
and processed for western-blotting at DIV18 (G). The graph reports the optical
density of the band relative to FGFR2, normalized vs. actin value. Data are
reported as mean ± SEM; N = 5, ∗p < 0.001 vs. siControl (H).
Supplementary Figure 3–63 | The figures report the original images
acquired at the microscope (upper lane), the images superimposed with
the relative neurite tracing elaborated on NeuronJ (middle lane) and the
tracings alone as they appear in the main figures (lower lane). Panels are
202× 202 µm large. Supplementary Figure 3B (not treated panel) exemplifies
the output of the software assisted neurite analysis: counted neurites are indicated
by a progressive number. The correlation among main and Supplementary Figures
is: Figure 1 = Supplementary Figure 3A; Figure 2 = Supplementary Figure
3B; Figure 3 = Supplementary Figure 4A; Figure 4 = Supplementary Figure
4B; Figure 5 = Supplementary Figure 5; Figure 6 = Supplementary
Figure 6.
Supplementary table 1 | The table reports the complete outcome of the
statistical analysis; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
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